Hyperfine (HYPR) Other Non-Current Assets (2020 - 2026)
Hyperfine's (HYPR) quarterly Other Non-Current Assets came in at $1.8 million in Q1 2026, down 4.1% YoY from $1.9 million in Q1 2025, and little changed on a QoQ basis from $1.8 million in Q4 2025.
Hyperfine (HYPR) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Hyperfine (HYPR) has 7 years of Other Non-Current Assets data on file, last reported at $1.8 million in Q1 2026.
- Quarterly Other Non-Current Assets fell 4.1% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 4.1% YoY) and the FY2025 annual result came in at $1.8 million, down 12.81% from the prior year.
- Other Non-Current Assets held at $1.8 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.3 million in Q4 2023 to a low of $1.2 million in Q3 2022.
- A 5-year average of $1.8 million and a median of $1.9 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 73.2% — and 2025, when it slipped 14.03%.
- Tracing HYPR's Other Non-Current Assets over 5 years: stood at $2.1 million in 2022, then grew by 7.15% to $2.3 million in 2023, then decreased by 9.73% to $2.1 million in 2024, then fell by 12.81% to $1.8 million in 2025, then declined by 0.06% to $1.8 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.8 million (Q1 2026), $1.8 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Hyperfine | 89.83 Mn | 45.06 Mn | 1.98 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Mn |
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 2.07 Mn |
| Sep 30, 2024 | 2.17 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.05 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.24 Mn |
| Dec 31, 2020 | 44,000.00 |